Abstract
We report a case of IgG lambda multiple myeloma with inaugural cutaneous xanthomatosis. A three years follow up showed parallel evolution of xanthomatosis and monoclonal gammapathy during therapy suggesting that the association is not coincidental. A decrease in IDL catabolism could be responsible. The monoclonal gammapathy could react with IDL and disturb the recognition of apolipoprotein E by its hepatic receptor.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Cyclophosphamide / therapeutic use
-
Female
-
Humans
-
Middle Aged
-
Multiple Myeloma / complications*
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / drug therapy
-
Paraproteinemias / complications
-
Prednisone / therapeutic use
-
Skin Diseases / diagnosis
-
Skin Diseases / etiology
-
Time Factors
-
Xanthomatosis / diagnosis
-
Xanthomatosis / etiology*
Substances
-
Cyclophosphamide
-
Prednisone